Journal article · 2005 · Open access

Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

Shôn W. Lewis, Thomas R. E. Barnes, Linda Mary Davies, Robin M. Murray, Graham Dunn, Karen Petra Hayhurst, Alison Markwick, Helen Mary Lloyd, Peter Brian Jones

Schizophrenia Bulletin, 32(4), 715–723 · Published 12 October 2005 · DOI 10.1093/schbul/sbj067

Open PDFView at the publisherCite this paper

In brief

“Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia” is a 2005 journal article by Shôn W. Lewis and 8 co-authors, published in Schizophrenia Bulletin. OpenAlex counts 450 citations as of 20 November 2026, which puts it in the top 2% of works published in 2005 by citations. It is open access: the full text is free to read at Schizophrenia Bulletin.

Citations
450
Most cited in
2020 (25)
Field-weighted impact
7.80
References
35
Authors
9

Abstract

There is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs in resistant schizophrenia. It is less clear if clozapine is more effective than the other second-generation antipsychotic (SGA) drugs. A noncommercially funded, pragmatic, open, multisite, randomized controlled trial was conducted in the United Kingdom National Health Service (NHS). Participants were 136 people aged 18-65 with DSM-IV schizophrenia and related disorders whose medication was being changed because of poor clinical response to 2 or more previous antipsychotic drugs. Participants were randomly allocated to clozapine or to one of the class of other SGA drugs (risperidone, olanzapine, quetiapine, amisulpride) as selected by the managing clinician. Outcomes were assessed blind to treatment allocation. One-year assessments were carried out in 87% of the sample. The intent to treat comparison showed no statistically significant advantage for commencing clozapine in Quality of Life score (3.63 points; CI: 0.46-7.71; p = .08) but did show an advantage in Positive and Negative Syndrome Scale (PANSS) total score that was statistically significant (-4.93 points; CI: -8.82 to -1.05; p = .013) during follow-up. Clozapine showed a trend toward having fewer total extrapyramidal side effects. At 12 weeks participants who were receiving clozapine reported that their mental health was significantly better compared with those receiving other SGA drugs. In conclusion, in people with schizophrenia with poor treatment response to 2 or more antipsychotic drugs, there is an advantage to commencing clozapine rather than other SGA drugs in terms of symptom improvement over 1 year.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lewis, S. W., Barnes, T. R. E., Davies, L. M., Murray, R. M., Dunn, G., Hayhurst, K. P., Markwick, A., Lloyd, H. M., & Jones, P. B. (2005). Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia. Schizophrenia Bulletin, 32(4), 715–723. https://doi.org/10.1093/schbul/sbj067

MLA 9

Lewis, Shôn W., et al. “Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia.” Schizophrenia Bulletin, vol. 32, no. 4, 2005, pp. 715–723. https://doi.org/10.1093/schbul/sbj067.

Chicago

Lewis, Shôn W., Thomas R. E. Barnes, Linda Mary Davies, Robin M. Murray, Graham Dunn, Karen Petra Hayhurst, Alison Markwick, Helen Mary Lloyd, and Peter Brian Jones. 2005. “Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia.” Schizophrenia Bulletin 32 (4): 715–723. https://doi.org/10.1093/schbul/sbj067.

Harvard

Lewis, S. W. et al. (2005) ‘Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia’, Schizophrenia Bulletin, 32(4), pp. 715–723. doi:10.1093/schbul/sbj067.

IEEE

S. W. Lewis et al., “Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia,” Schizophrenia Bulletin, vol. 32, no. 4, pp. 715–723, 2005, doi: 10.1093/schbul/sbj067.

BibTeX

@article{lewis2005randomized,
  title     = {{Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia}},
  author    = {Lewis, Shôn W. and Barnes, Thomas R. E. and Davies, Linda Mary and Murray, Robin M. and Dunn, Graham and Hayhurst, Karen Petra and Markwick, Alison and Lloyd, Helen Mary and Jones, Peter Brian},
  journal   = {Schizophrenia Bulletin},
  year      = {2005},
  volume    = {32},
  number    = {4},
  pages     = {715--723},
  doi       = {10.1093/schbul/sbj067},
  url       = {https://doi.org/10.1093/schbul/sbj067}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20172121
20181616
20191818
20202525
20211616
202288
202399
20241515
20251717
202677

Its field-weighted citation impact is 7.80: it has been cited 7.80 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • clozapine
  • atypical antipsychotics

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Lewis, S. W., Barnes, T. R. E., Davies, L. M., Murray, R. M., Dunn, G., Hayhurst, K. P., Markwick, A., Lloyd, H. M., & Jones, P. B. (2005). Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia. Schizophrenia Bulletin, 32(4), 715–723. https://doi.org/10.1093/schbul/sbj067

How many times has this paper been cited?

450 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Schizophrenia Bulletin: sign in and open the PDF from this page.

Who wrote this paper?

Shôn W. Lewis, Thomas R. E. Barnes, Linda Mary Davies, Robin M. Murray, Graham Dunn, Karen Petra Hayhurst, Alison Markwick, Helen Mary Lloyd, Peter Brian Jones.

What is the DOI of this paper?

10.1093/schbul/sbj067, permanently at https://doi.org/10.1093/schbul/sbj067. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.